Lung Diseases

Subtype terms (28)

More specific conditions that are subtypes of Lung Diseases in the MeSH hierarchy.

• Acute Chest Syndrome

  12 drugs (11 approved, 1 experimental)

• alpha 1-Antitrypsin Deficiency

  36 drugs (14 approved, 22 experimental)

• Cystic Adenomatoid Malformation of Lung, Congenital

  3 drugs approved

• Cystic Fibrosis

  329 drugs (163 approved, 166 experimental)

• Hemoptysis

  8 drugs (7 approved, 1 experimental)

• Hemosiderosis, Pulmonary
• Hepatopulmonary Syndrome

  6 drugs approved

• Hypertension, Pulmonary

  173 drugs (110 approved, 63 experimental)

• Lung Abscess

  4 drugs approved

• Lung Diseases, Fungal

  5 drugs (4 approved, 1 experimental)

• Lung Diseases, Interstitial

  95 drugs (61 approved, 34 experimental)

• Lung Diseases, Obstructive

  27 drugs (20 approved, 7 experimental)

• Lung Diseases, Parasitic
• Lung, Hyperlucent
• Lung Injury

  16 drugs (13 approved, 3 experimental)

• Lung Neoplasms

  992 drugs (345 approved, 647 experimental)

• Plasma Cell Granuloma, Pulmonary
• Pneumonia

  284 drugs (176 approved, 108 experimental)

• Pulmonary Alveolar Proteinosis

  7 drugs (4 approved, 3 experimental)

• Pulmonary Atelectasis

  16 drugs approved

• Pulmonary Edema

  24 drugs (20 approved, 4 experimental)

• Pulmonary Embolism

  73 drugs (55 approved, 18 experimental)

• Pulmonary Eosinophilia

  5 drugs (4 approved, 1 experimental)

• Pulmonary Veno-Occlusive Disease

  3 drugs approved

• Respiratory Distress Syndrome

  225 drugs (123 approved, 102 experimental)

• Scimitar Syndrome
• Solitary Pulmonary Nodule

  6 drugs (3 approved, 3 experimental)

• Tuberculosis, Pulmonary

  96 drugs (61 approved, 35 experimental)

Drugs by status

Organizations

ICD-10 crosswalk

• J98.4 — Other disorders of lung